Constantine S. Mihas - 26 May 2026 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Reporting relationship: Director
Issuer ticker: MRVI
Reported as of: 26 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2026, 18:26:55 UTC
Prior SEC filing: 18 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Kurt Oreshack, by power of attorney for Constantine Mihas

Key filing fact

Constantine S. Mihas filed Form 4 for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) on 28 May 2026.

Key facts

This page summarizes Constantine S. Mihas's Form 4 filing for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 May 2026, 18:26.

Change

Previous filing in this sequence was filed on 18 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001262930 Primary reporting owner

MIHAS CONSTANTINE S

Relationship: Director
Address: C/O GTCR, LLC, 300 N. LASALLE SUITE 5600, CHICAGO
Signature: /s/ Kurt Oreshack, by power of attorney for Constantine Mihas
Signature date: 28 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRVI transaction

Class A Common Stock

Award

Transaction value
Shares: +46,293
Change %: +34%
Price: $0.000000^*
Shares after: 184,348
Date: 26 May 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

Footnote F2

The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16.